Medicare Enrolled

Dr. Zeyad Metwalli, M.D.

Radiation Oncology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2002 HOLCOMBE BLVD, Houston, TX 77030
7137941414
In practice since 2009 (17 years)
NPI: 1821230434 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Metwalli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Metwalli? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Metwalli

Dr. Zeyad Metwalli is a radiation oncology specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Metwalli performed 449 Medicare services across 429 unique beneficiaries.

Between the years covered by Open Payments, Dr. Metwalli received a total of $9,949 from 18 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Metwalli is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 449 Medicare services $9,949 industry payments

Medicare Practice Summary

Medicare Utilization ↗
449
Medicare services
Bottom 18% in TX for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
429
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Fluoroscopic guidance for insertion or removal of central vein access device 51 $14 $317
Review by radiologist of ct guidance for needle placement 49 $55 $518
Ultrasonic guidance for blood vessel access 47 $11 $150
Insertion of central venous tube with port (5 years or older) 45 $260 $3,049
Ultrasonic guidance for needle placement 45 $24 $393
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 44 $10 $120
Chest X-ray, 1 view 28 $7 $88
Drainage of fluid from abdominal cavity using imaging guidance 26 $80 $942
Injection of biodegradable material next to prostate 23 $126 $1,593
Needle biopsy of growth of abdominal cavity 21 $61 $1,077
Placement of device in prostate for radiation therapy 21 $40 $1,104
Ultrasound of both sides of head and neck blood flow 18 $27 $639
Needle biopsy of liver through skin 17 $68 $1,125
Needle biopsy or removal of surface lymph nodes 14 $66 $1,196
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,949
Total received (2018-2024)
Avg $1,421/year across 7 years
Top 7% in TX for radiation oncology
18
Companies
57
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,747 (67.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,202 (32.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,304
2023
$953
2022
$662
2021
$255
2020
$161
2019
$1,029
2018
$3,585

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$3,229
HISTOSONICS, INC.
$1,793
Boston Scientific Corporation
$1,511
Biocompatibles, Inc.
$630
Inari Medical, Inc.
$514
Sirtex Medical Inc
$462
Medtronic, Inc.
$374
GE HealthCare
$346
Bard Peripheral Vascular, Inc.
$187
Delcath Systems
$140
Penumbra, Inc.
$123
BOSTON SCIENTIFIC CORPORATION
$116
Endocare, Inc.
$113
BARD PERIPHERAL VASCULAR, INC.
$109
Medtronic Vascular, Inc.
$93
Siemens Medical Solutions USA, Inc.
$85
Terumo Medical Corporation
$83
EKOS Corporation
$41
Top 3 companies account for 65.7% of total payments
Associated products mentioned in payments ›
AZUR · Artis Q ceiling · Concerto · EKOSONIC · EMPRINT · FLOWTRIEVER CATHETER · GENERAL THERAPIES · HEPZATO KIT · Indigo System · LUTONIX · NANOKNIFE · OSTEOCOOL RF ABLATION SYSTEM · S · SIR-Spheres Microspheres · SpaceOAR VUE System - 10mL · THERASPHERE · THERASPHERE - BIO · THERASPHERE-BIO · TheraSphere Y90 Glass Microspheres 10 GBq · VENOVO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for radiation oncology in TX.

Equivalent to $2,216 per 100 Medicare services performed
Looking for a radiation oncology specialist in Houston?
Compare radiation oncologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
765
Per 100K population
16.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Metwalli is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Metwalli experienced with fluoroscopic guidance for insertion or removal of central vein access device?
Based on Medicare claims data, Dr. Metwalli performed 51 fluoroscopic guidance for insertion or removal of central vein access device services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Metwalli receive payments from pharmaceutical companies?
Yes. Dr. Metwalli received a total of $9,949 from 18 companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Metwalli's costs compare to other radiation oncologists in Houston?
Dr. Metwalli's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Metwalli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Radiation Oncologists in Houston
Browse radiation oncologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Radiation Oncologists in TX
Radiation oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiation Oncologists in TX
Which TX radiation oncologists receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc.
By company
HISTOSONICS, INC. Payments to Doctors
See all physicians who received payments from HISTOSONICS, INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →